Disease Progression: all 402 studies
Page 2 of 5. Open to participants first (112), then studies with results posted, then the rest; newest registration first within each.
- Dimensional and Developmental Profiles of Psychosis in Children and AdolescentsRecruitingNCT04370730Not applicable
- Serum and Cellular Biomarkers for Aortic Valve StenosisRecruitingNCT04312139
- Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung CancerRecruitingNCT04300062Not applicable
- Prospective Collection of Samples for Urothelial Cancer of BladderNot yet recruitingNCT04167332
- Prospective Sample Collection for Cancer of BladderRecruitingNCT03973671
- Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver DiseaseRecruitingNCT03635541
- Pronostic and Predictive Value of EMT in Localized Lung CancerRecruitingNCT03509779
- Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and PsoriasisRecruitingNCT03361215
- Combination of TATE and PD-1 Inhibitor in Liver CancerRecruitingNCT03259867Phase 2
- Transformative Research in Diabetic NephropathyRecruitingNCT02986984
- NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)RecruitingNCT02327897
- RegisterNET - A Registry for Neuroendocrine Tumors in the USA and WorldwideEnrolling by invitationNCT02270567
- A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsCompletedNCT05712356Phase 2Results posted
- A Study to Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin AmyloidosisCompletedNCT05139680Results posted
- Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney DiseaseCompletedNCT05085275Phase 3Results posted
- Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive DiseaseTerminatedNCT04685499Phase 2Results posted
- Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 ProgressionCompletedNCT04491994Phase 3Results posted
- Treatment Resistance Following Anti-cancer TherapiesTerminatedNCT04436120Not applicableResults posted
- Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel TherapyTerminatedNCT04149821Phase 2Results posted
- sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate CancerStatus unknownNCT04033432Phase 2Results posted
- Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic CarcinomaCompletedNCT03990571Phase 2Results posted
- Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord EpendymomaTerminatedNCT03727841Phase 2Results posted
- Assessing Tele-Health Outcomes in Multiyear Extensions of PD TrialsCompletedNCT03538262Results posted
- Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT03374332Phase 1/2Results posted
- A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03170232Phase 2Results posted
- Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
- A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDRTerminatedNCT02681809Phase 2Results posted
- Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine PracticeCompletedNCT02533258Results posted
- Real-PD Trial: Development of Clinical Prognostic Models for Parkinson's DiseaseCompletedNCT02474329Results posted
- Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate SystemCompletedNCT02392078Results posted
- Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)CompletedNCT02322320Phase 3Results posted
- TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)CompletedNCT02043847Phase 1Results posted
- Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency DepartmentCompletedNCT01947127Results posted
- PET Enhanced CT Scan Performance in CancerCompletedNCT01881620Not applicableResults posted
- Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)Active, not recruitingNCT01782352Not applicableResults posted
- TRC105 for Recurrent GlioblastomaTerminatedNCT01778530Phase 2Results posted
- Laser Ablation After Stereotactic RadiosurgeryCompletedNCT01651078Results posted
- An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 DiabetesCompletedNCT01400971Results posted
- Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective DataCompletedNCT01145898Results posted
- Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)CompletedNCT01109004Phase 3Results posted
- A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade GliomasCompletedNCT00995007Phase 2Results posted
- Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VDCompletedNCT00908232Phase 2Results posted
- A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney DiseaseTerminatedNCT00830037Phase 4Results posted
- Bevacizumab and Irinotecan to Treat Brain TumorsTerminatedNCT00393094Phase 2Results posted
- Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-inflammatory Effect of ChloroquineTerminatedNCT00308620Phase 2/3Results posted
- Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage ITerminatedNCT00171925Phase 3Results posted
- Tamoxifen and Bortezomib to Treat Recurrent Brain TumorsCompletedNCT00108069Phase 2Results posted
- An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral TherapyCompletedNCT00004978Phase 3Results posted
- Divergent Long-Term Clinical Courses in Two Men With Breast CancerCompletedNCT07865507
- Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter StudyCompletedNCT07798479
- Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary DiseaseActive, not recruitingNCT07712016
- Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective StudyCompletedNCT07657299
- IPF Longitudinal Natural History StudyActive, not recruitingNCT07560189
- Epidemiology and Treatment of HR+/HER2- Breast Cancer in EnglandCompletedNCT07498413
- THE EFFECTS OF AEROBİC EXERCİSE ON NEUROVASCULAR UNİT AND CLİNİCAL PROGRESSİON MARKERS İN INDİVİDUALS WİTH MULTİPLE SCLEROSİSCompletedNCT07325019Not applicable
- Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple SclerosisActive, not recruitingNCT07235644
- Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney DiseaseActive, not recruitingNCT06962891
- Off-script Diagnosis & Differential Diagnosis (D&D) Training and Residents' Stroke KnowledgeCompletedNCT06941753Not applicable
- Description of Patients With Type 1 Diabetes Treated With TeplizumabCompletedNCT06892002
- Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNBCompletedNCT06887023
- Effects of Progressive Relaxation ExercisesCompletedNCT06867575Not applicable
- The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis DeterminationActive, not recruitingNCT06751251
- Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese PatientsActive, not recruitingNCT06635447Phase 3
- Ultrasonographic Muscle Assessment and Functional Scales in Spinal Muscular AtrophyActive, not recruitingNCT06599606
- Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine TherapyCompletedNCT06558084
- Dynamic Pattern of Etiology, Immunoinflammatory Factors and Their Association With Prognosis of Severe PneumoniaActive, not recruitingNCT06538441
- Propionic Acid in Multiple SclerosisCompletedNCT06402487Phase 2/3
- A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)Active, not recruitingNCT06355531Phase 2
- Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder CancerCompletedNCT06235853
- High Frequency Imaging in Cerebral Amyloid AngiopathyActive, not recruitingNCT06128824
- Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing DataCompletedNCT05983003
- Prospective Evaluation of NfL as a Biomarker in ATTRvActive, not recruitingNCT05879874
- Studying the Efficiency of the Natural Preparation Rutan in Children in the Treatment of COVID-19, ARVICompletedNCT05862883Phase 2
- The Effects of Mindfulness-based Cognitive Therapy in People With Parkinson's DiseaseActive, not recruitingNCT05779137Not applicable
- The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder CancerStatus unknownNCT05704231Not applicable
- Neuromelanin MRI: A Progression Marker in Early PDStatus unknownNCT05631158
- Correlation Between Thermal Patterns of Infrared Thermal Imaging and Clinical Phenotype in Patients With Postherpetic NeuralgiaStatus unknownNCT05568186
- The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer SurgeryStatus unknownNCT05560035Not applicable
- Treatment of Recurrent GBM With APG-157 Via Expanded AccessNo longer availableNCT05551013
- Continuous and Wireless Vital Sign Monitoring in Patients at Home After Acute Medical AdmissionCompletedNCT05536206
- Personalized Parkinson Project PSP CohortCompletedNCT05501431
- Identification and Characterization of Diabetes in Low-resource PopulationsStatus unknownNCT05487079
- Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric CancerStatus unknownNCT05397548
- Progression Assessment of Carotid Artery Stenosis by Ultrafast Ultrasound Flow ImagingActive, not recruitingNCT05270005
- 3 Year Follow up on ANO5 PatientsActive, not recruitingNCT05206617
- Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLLTerminatedNCT05153330Phase 1
- Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled TrialStatus unknownNCT05146635Not applicable
- Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearrangedWithdrawnNCT05116618
- Kidney AI-enabled Care TransformationWithdrawnNCT05056909Not applicable
- Enhancing Gait Using Alternating-Frequency DBS in Parkinson DiseaseActive, not recruitingNCT05022147Phase 1
- Sensitivity of Motor Assessment in MS - a Prospective Cohort StudyStatus unknownNCT04993274
- Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell CarcinomaCompletedNCT04987203Phase 3
- The Personalized Parkinson Project De Novo CohortActive, not recruitingNCT04985539
- Aging and Disease Course: Contributions to Lifespan Neurobiology of SchizophreniaCompletedNCT04951700
- Natural History Study of COVID-19 Using Digital WearablesCompletedNCT04927442
- Energy for LymphocytesCompletedNCT04879316
- Intrapartum Translabial Ultrasonography ReliabilityStatus unknownNCT04844437
- Early Detection of Clinical Deterioration in Patients With COVID-19 Using Machine LearningStatus unknownNCT04828915
- Predicting Disease Progression and/or Recurrence in CancerCompletedNCT04776837
- Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological MarkersCompletedNCT04723121Not applicable